Bank of America Securities Keeps Their Hold Rating on Alkermes …

3 days ago · In a report released today, Jason Gerberry from Bank of America Securities maintained a Hold rating on Alkermes (ALKS – Research Report). The company’s shares opened today at $29.23. According ...

CouponFollow Extension

$29.23
OFF

Bank Of America Securities Keeps Their Hold Rating On Alkermes …

1 week from now

businessinsider.com

$32.00
OFF

Bank Of America Securities Keeps Their Hold Rating On Alkermes …

1 week from now

Jul 27, 2023 · Bank of America Securities analyst Jason Gerberry reiterated a Hold rating on Alkermes (ALKS – Research Report) yesterday and set a price target of $32.00. The …

businessinsider.com

$31
OFF

Alkermes Price Target Raised To $31 From $28 At BofA - Nasdaq

1 week from now

2 days ago · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer …

nasdaq.com

8%
OFF

IBD Rating Upgrades: Alkermes Flashes Improved Relative Price …

1 week from now

3 days ago · Earnings-per-share growth dropped last quarter from -8% to -16%, but the top line rose from -35% to -1%. Alkermes holds the No. 45 rank among its peers in the Medical …

investors.com

$650
OFF

Alkermes Upgraded To Neutral At BofA On Improved Risk/reward …

1 week from now

BofA Securities has upgraded Alkermes to hold from underperform as it sees peak sales of ~$650M from bipolar disorder treatment Lybalvi (olanzapine and samidorphan).The firm,...

seekingalpha.com

$40.00
OFF

Alkermes (NASDAQ:ALKS) Given New $40.00 Price Target At …

1 week from now

2 days ago · Cantor Fitzgerald decreased their target price on Alkermes from $48.00 to $43.00 and set an "overweight" rating for the company in a report on Friday, October 25th. Finally, …

marketbeat.com

$33.00
OFF

Alkermes: Hold Rating Affirmed Amid EBITDA Growth And …

1 week from now

Feb 16, 2024 · In a report released yesterday, Jason Gerberry from Bank of America Securities reiterated a Hold rating on Alkermes (ALKS – Research Report), with a price target of $33.00. …

businessinsider.com

4%
OFF

Bank Of Montreal Can Boosts Stock Position In Alkermes Plc

1 week from now

Oct 6, 2024 · Bank of Montreal Can lifted its position in Alkermes plc (NASDAQ:ALKS - Free Report) by 111.4% during the second quarter, according to its most recent Form 13F filing with …

marketbeat.com

$1.86
OFF

Bank Of America Securities Keeps Their Sell Rating On Agilon …

1 week from now

Nov 8, 2024 · Bank of America Securities analyst Adam Ron maintained a Sell rating on Agilon Health (AGL – Research Report) today. The company’s shares opened today at $1.86. …

businessinsider.com

FAQs about Bank of America Securities Keeps Their Hold Rating on Alkermes … Coupon?

Is Alkermes (AlkS) a good stock to buy?

In a report released today, Jason Gerberry from Bank of America Securities maintained a Hold rating on Alkermes (ALKS – Research Report). The company’s shares opened today at $29.23. According to TipRanks, Gerberry is a 4-star analyst with an average return of 2.8% and a 46.90% success rate. ...

Did health Alkermes report more revenue than expected?

Health Alkermes Reported More Revenue Than Expected. Here’s Why the Stock Is Falling. Shares of Alkermes were down 2.74% after the Food and Drug Administration published a warning letter alleging Vivitrol ads didn't include important risk information. If Vivitrol, which is used to prevent relapses in opioi... ...

Should you buy Alkermes (Alkermes)?

Gerberry covers the Healthcare sector, focusing on stocks such as Oculis Holding, Exelixis, and Jazz Pharmaceuticals. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alkermes with a $37.57 average price target. The company has a one-year high of $33.71 and a one-year low of $21.75. ...

Did Alkermes make a profit?

Based on Alkermes’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $378.14 million and a net profit of $92.38 million. In comparison, last year the company earned a revenue of $380.94 million and had a net profit of $47.76 million ...